Newstral
Article
pressherald.com on 2023-01-17 00:19
Obesity treatments catch drugmakers’ eyes as sales seen soaring
Related news
- Obesity treatments the new $40b pharma frontierSydney Morning Herald
- How Well Do COVID-19 Treatments Work Against Omicron? Here’s What Drugmakers Sayobserver.com
- MDrugmakers examine effectiveness of COVID-19 vaccines and treatments against new, more infectious South African strainmarketwatch.com
- Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatmentsseattletimes.com
- Pfizer moves beyond COVID vaccines to become leader in cancer, obesity treatmentsjournalrecord.com
- FDrugmakers rush to adapt Covid treatments to mutant strainsft.com
- Drugmakers and scientists begin the hunt for long COVID treatmentsThe Japan Times
- Medical Edge: Catch for ObesityLocal 12
- Marijuana Stocks Continue to Catch Analysts’ Eyes, Potentially Making Them Prime Investmentsprofitconfidential.com
- Rams’ Tutu Atwell, Puka Nacua catch 49ers’ eyes ahead of NFC West battleLA Times
- A sight for soaring eyesThe Day
- Drugmakers investing in biotech companiesnwaonline.com
- Scientists unravel how obesity gene works; new treatments possibleDallas News
- Novo Nordisk net profit jumps on diabetes, obesity treatmentstimesofmalta.com
- MNovo Nordisk profit beats on strength in diabetes, obesity treatmentsmarketwatch.com
- Itching eyes in children: Causes and treatmentstribuneonlineng.com
- Rare genetic aversion to sweets could unlock treatments for obesitypressherald.com
- Americans Increase Demand for Obesity Treatments in Brazilbocaratontribune.com
- Older Americans to pay less for some drug treatments as drugmakers penalized for big price jumpsSeattle Times